05/13/2024 6:01 AM | iTeos Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/10/2024 3:35 PM | iTeos Therapeutics (Filer)
| Form 424B5 | |
05/10/2024 7:31 AM | iTeos Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024 6:13 AM | iTeos Therapeutics (Filer)
| Form ARS | |
04/25/2024 6:03 AM | iTeos Therapeutics (Filer)
| Form DEF 14A | |
04/25/2024 6:07 AM | iTeos Therapeutics (Filer)
| Form DEFA14A | |
03/08/2024 6:57 PM | Detheux Michel (Reporting) iTeos Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/08/2024 6:58 PM | iTeos Therapeutics (Issuer) McGrath Yvonne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 7:00 PM | Call Matthew (Reporting) iTeos Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 7:01 PM | Gall Matthew (Reporting) iTeos Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 7:00 PM | DeSimone Jill (Reporting) iTeos Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
03/07/2024 7:01 PM | DeSimone Jill (Reporting) iTeos Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 6:09 AM | iTeos Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/06/2024 6:19 AM | iTeos Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/16/2024 11:54 AM | EcoR1 Capital, LLC (Filed by) iTeos Therapeutics (Subject)
| Form SC 13G | |
02/14/2024 8:45 AM | BIOTECHNOLOGY VALUE FUND L P (Filed by) iTeos Therapeutics (Subject)
| Form SC 13G/A | |
01/10/2024 4:00 PM | iTeos Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/09/2024 3:26 PM | iTeos Therapeutics (Subject) MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
12/07/2023 7:20 PM | Detheux Michel (Reporting) iTeos Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/07/2023 7:21 PM | Gall Matthew (Reporting) iTeos Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/07/2023 7:22 PM | Call Matthew (Reporting) iTeos Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/07/2023 7:22 PM | iTeos Therapeutics (Issuer) McGrath Yvonne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/07/2023 7:16 PM | iTeos Therapeutics (Issuer) Lee David K (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/07/2023 7:17 PM | iTeos Therapeutics (Issuer) Lee David K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/07/2023 6:06 AM | iTeos Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/24/2023 3:12 PM | iTeos Therapeutics (Subject) MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G | |
10/12/2023 4:09 PM | Gall Matthew (Reporting) iTeos Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/25/2023 8:28 PM | Boxer Asset Management Inc. (Reporting) Boxer Capital, LLC (Reporting) Davis Aaron I. (Reporting) iTeos Therapeutics (Issuer) LEWIS JOSEPH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2023 8:35 PM | Boxer Capital, LLC (Reporting) iTeos Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2023 6:02 AM | iTeos Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
06/26/2023 6:53 AM | iTeos Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/20/2023 6:04 AM | iTeos Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/15/2023 6:52 PM | Davis Aaron I. (Reporting) iTeos Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 6:53 PM | DiRocco Derek (Reporting) iTeos Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 6:54 PM | Hallal David (Reporting) iTeos Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 6:55 PM | Ho Tony W (Reporting) iTeos Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 6:55 PM | Iannone Robert (Reporting) iTeos Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 6:56 PM | iTeos Therapeutics (Issuer) RHOADS ANN D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 6:57 PM | iTeos Therapeutics (Issuer) Van Hauwermeiren Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2023 11:15 PM | iTeos Therapeutics (Filer)
| Form EFFECT | |